MedTrace Logo

AZD0914 Phase 1 ADME Study in Healthy Volunteers

NCT02298920 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-06-03

No results posted yet for this study

Summary

This study will investigate the metabolic fate and routes of excretion of 14CAZD0914 in six male healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

AZD0914

Radiolabelled AZD0914 for study of absorption, disposition, metabolism, and excretion in healthy volunteers.

Sponsors & Collaborators

  • Entasis Therapeutics

    lead INDUSTRY

Principal Investigators

  • Irene Mirkin, MD · Covance Clinical Research Unit

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02298920 on ClinicalTrials.gov